Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
To investigate the role of the hepatitis C virus internal ribosome entry site (HCV IRES) domain IV in translation initiation and regulation, two chimeric IRES elements were constructed to contain the reciprocal domain IV in the otherwise HCV and classical swine fever virus IRES elements. This permitted an examination of the role of domain IV in the control of HCV translation. A specific inhibitor of the HCV IRES, vitamin B(12), was shown to inhibit translation directed by all IRES elements which contained domain IV from the HCV and the GB virus B IRES elements, whereas the HCV core protein could only suppress translation from the wild-type HCV IRES. Thus, the mechanisms of translation inhibition by vitamin B(12) and the core protein differ, and they target different regions of the IRES.
Macfarlane Burnet Institute for Medical Research and Public Health, GPO Box 2284, Melbourne, VIC 3001, Australia.
Dongsheng
D
Li
William B
WB
Lott
John
J
Martyn
Gholamreza
G
Haqshenas
Eric J
EJ
Gowans
D016174:Hepacivirus / Q000502:physiology*; D014176:Protein Biosynthesis; D012270:Ribosomes / Q000737:chemistry / Q000378:metabolism*; D014758:Viral Core Proteins / Q000502:physiology*; D014805:Vitamin B 12 / Q000494:pharmacology*
D014758:Viral Core Proteins; D014805:Vitamin B 12